Immunotherapy with chemotherapy — why both are given together

Because the two treatments work in completely different ways at the same time. Chemotherapy kills cancer cells that are actively dividing. Checkpoint inhibitor immunotherapy aims to release a brake on your own immune cells so they can find cancer. Given together, each is intended to do something the other cannot.

There is a second reason, and it is the more interesting one. When chemotherapy damages cancer cells, some of them break open and release fragments into the surrounding tissue. Those fragments can make the cancer easier for the immune system to recognise. Chemotherapy is not only killing cells; it is also intended to make the immune system's job easier. NCCN, ASCO and ESMO set out this rationale in their patient-facing material on combination treatment.

This is why the combination has become the commonest first treatment plan in advanced lung cancer, and why it is used in several other cancers too. It is not an experiment, and it is not two treatments improvised together. It is a defined regimen with a set number of cycles, given as day care.

Whether it applies to you is a decision for your treating team. Cancer type, stage, biomarker results, kidney and liver function, other illnesses and how well you are day to day all feed into it. Nothing on this page can make that call, and it is not meant to.

Chemotherapy acts on the cancer and usually shows an effect within the first few cycles. Immunotherapy acts on your immune system and can take longer to show anything on a scan. They are often given in the same session on the same day, but they are doing two separate jobs on two different timescales.

Both treatments are given as day care at CION centres. Response-assessment imaging is coordinated at partner imaging centres.

If your oncologist has advised chemotherapy without immunotherapy, that is a common and appropriate plan — not a lesser one. The reverse is equally true. Ask which of the three your plan is, and why. It is a fair question and you should get a clear answer.

No. Side effects are not doubled. They do overlap and add up, and the combination is harder than either treatment alone, but the two parts mostly cause different problems. The honest summary is that you should expect more side effects than with one treatment, not twice as many.

They are not simply doubled because the two halves affect the body through different mechanisms. Chemotherapy side effects are largely predictable and follow the cycle: worst in the days after an infusion, then improving before the next one. Immune-related side effects are inflammation of an organ, and they do not follow that pattern at all. They can appear at any point, including after the chemotherapy part has finished.

That difference is the most useful thing to understand here. Knowing which half a symptom is likely coming from changes what your team does about it, and how quickly.

Some immune reactions become serious quickly. New or worsening loose motions, new breathlessness or a new cough, chest pain, or severe abdominal pain are reasons to contact your oncology team the same day, or call the CION helpline on 1800 202 8726. If you cannot reach anyone, go to the emergency department now and tell them you are on immunotherapy. Do not wait for your next cycle.

Yes, order matters, and it is set by your treating team before the first cycle. There are three broad patterns, plus the option of not combining at all. Which one you are on depends on your cancer, your biomarker results and how well you are — not on preference, and not on which sounds strongest.

1. 1

   Both from cycle one

   The commonest combination pattern. Chemotherapy and immunotherapy are given in the same day-care session, for a set number of cycles planned at the start.

2. 2

   Chemotherapy finishes, immunotherapy continues

   The chemotherapy cycles complete, and immunotherapy carries on alone for a longer planned period. Appointments usually get shorter. This is intended, and does not mean anything has gone wrong.

3. 3

   One after the other, not together

   Less often, the two are given in sequence rather than at the same time — usually because of fitness, other illnesses, or how the cancer is behaving.

4. 4

   One or the other, not both

   For some cancers and some biomarker results, immunotherapy alone or chemotherapy alone is the guideline-backed plan. Adding the other half is not automatically better.

If the plan changes part-way through, ask what changed and why. Sequencing decisions belong with your treating team, and every reasonable team will explain the reasoning in plain language.

Anything else you are taking. Some ordinary medicines, some supplements and some traditional remedies can interact with one half of the combination, or make a side effect harder to read correctly. The single most useful thing you can do is give your oncology team a complete, honest list.

• Immunotherapy and Antibiotics: Does One Interfere With the Other? — antibiotics come up often during a combination plan, because the chemotherapy half raises infection risk. This page covers what is currently understood, and what is still genuinely uncertain.
• Can You Take Ayurvedic or Herbal Medicines With Immunotherapy? — many families across Telangana and Andhra Pradesh use Ayurvedic or herbal preparations alongside hospital treatment. The point is not to dismiss them. The point is that your oncologist knows, so nothing gets misread as a treatment side effect.
• Immune Boosters, Supplements and Immunotherapy — why “boosting” the immune system during immunotherapy is not as straightforward as it sounds, and which supplements are worth raising with your team before you start.

Most of the fear around combining these two treatments comes from not knowing which decisions have already been made, and why. These five questions get you that in one conversation.

• Is my plan chemotherapy alone, immunotherapy alone, or both together — and why that one?
• How many cycles of each are planned, and what happens after the chemotherapy part ends?
• Which side effects should I report the same day, and which can wait for my next visit?
• Which of my existing medicines, supplements and home remedies should I stop, and which are fine to continue?
• What is the estimated cost of the full plan, and what will insurance or a government scheme cover?

A 45-minute consultation at CION is designed to leave you with those answers in writing rather than in memory. You can read more about how the service is delivered on Immunotherapy at CION Cancer Clinics — including how treatment is given as day care and how response scans are coordinated with our partner imaging centres. Any cost figure quoted is indicative, as of August 2026, and is confirmed in writing before treatment starts.

This page is general information and does not replace a consultation. It describes drug classes only, not specific medicines or regimens, and it recommends no treatment. The side-effect patterns and combination rationale here are drawn from NCCN, ASCO and ESMO patient-education guidance; they are general, and no outcome figure of any kind is implied. Every decision about whether to combine treatments, and in what order, belongs with your own treating team.

Get a second opinion on your combination plan

Free, written, and reviewed by our tumour board — so you begin treatment knowing exactly why each part is there.